ArticleAngewandte Chemie (International ed. in English)2026
A Revised Model for Muscarine Biosynthesis Involving Lysine Trimethylation.
Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
l-(+)-Muscarine is a widespread fatal toxin produced by various mushrooms that pose a severe threat to human health when they are mistaken for edible species. Apart from a single 1970s study that assumed l-glutamate and pyruvate were the building blocks of this unusual quaternary amine, surprisingly little is known about the toxin's biogenesis. We used Collybia rivulosa (syn. Clitocybe rivulosa), a mushroom notorious for producing muscarine, as our model for stable isotope incorporation experiments and subsequent extensive mass spectrometric analysis. Our results provide unambiguous evidence that the backbone of muscarine is assembled from two amino acids, l-lysine and l-alanine. Furthermore, we found that iterative ε-methylation of non-protein-bound l-lysine is the biosynthetic gateway step that yields ε-N,N,N-trimethyl-l-lysine. This methylation is specific to fungi that produce muscarine. Despite a substrate overlap with the biosynthesis of l-carnitine, we demonstrate that these two pathways are distinct. Our results provide compelling insight into the biogenetic origin of muscarine and fundamentally revise the previous biosynthetic model for this infamous toxin. The revised biosynthesis model lays the foundation to discover as yet unknown muscarine-like metabolites that are potentially toxic as well or pharmacologically relevant.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.